Physician profile
Marlee Bruno
NPI 1972838928
$19,343.22
in general payments reported to CMS, 2019-2025
6 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $2,815 · 2023: $8,900 · 2024: $7,002 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,905 · Travel and Lodging: $5,540 · Food and Beverage: $4,954 · Education: $5.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,905.13 |
| Travel and Lodging | $5,540.17 |
| Food and Beverage | $4,953.96 |
| Education | $5.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $18,147.64 | 2022-2025 | Xeomin |
| Revance Therapeutics, INC. | $601.85 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $422.16 | 2021-2024 | Dysport |
| Novo Nordisk INC | $88.08 | 2021-2022 | |
| Allergan, INC. | $42.20 | 2022 | |
| Abbvie INC. | $41.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlee Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.